{"id":"https://openalex.org/W2072795293","doi":"https://doi.org/10.1016/j.bbmt.2006.12.067","title":"64: Interleukin-6 and hematopoietic soluble factors confers resistance to trail mediated apoptosis","display_name":"64: Interleukin-6 and hematopoietic soluble factors confers resistance to trail mediated apoptosis","publication_year":2007,"publication_date":"2007-01-26","ids":{"openalex":"https://openalex.org/W2072795293","doi":"https://doi.org/10.1016/j.bbmt.2006.12.067","mag":"2072795293"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbmt.2006.12.067","doi":"https://doi.org/10.1016/j.bbmt.2006.12.067","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2006.12.067","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.bbmt.2006.12.067","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108298475","display_name":"Lia Elena Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.E. Perez","raw_affiliation_strings":["BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015224019","display_name":"Nancy Parquet","orcid":"https://orcid.org/0009-0009-8973-8418","observed_orcids":["https://orcid.org/0009-0009-8973-8418"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Parquet","raw_affiliation_strings":["BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Shain","raw_affiliation_strings":["Hematology Division, H. Lee Moffit Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division, H. Lee Moffit Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030664270","display_name":"Marina Molisano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Molisano","raw_affiliation_strings":["BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069500102","display_name":"R Nimmanapalli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Nimmanapalli","raw_affiliation_strings":["Hematology Division, H. Lee Moffit Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division, H. Lee Moffit Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087799564","display_name":"Melissa Alsina","orcid":"https://orcid.org/0000-0003-4946-823X","observed_orcids":["https://orcid.org/0000-0003-4946-823X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Alsina","raw_affiliation_strings":["BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060783496","display_name":"Claudio Anasetti","orcid":"https://orcid.org/0000-0002-0119-0622","observed_orcids":["https://orcid.org/0000-0002-0119-0622"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Anasetti","raw_affiliation_strings":["BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT Division, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103061547","display_name":"William S. Dalton","orcid":"https://orcid.org/0000-0001-9417-2599","observed_orcids":["https://orcid.org/0000-0001-9417-2599"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Dalton","raw_affiliation_strings":["Hematology Division, H. Lee Moffit Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division, H. Lee Moffit Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1353524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"2","first_page":"26","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.878000020980835},{"id":"https://openalex.org/keywords/trail-resistance","display_name":"TRAIL resistance","score":0.859000027179718},{"id":"https://openalex.org/keywords/hematopoietic-stromal-cells","display_name":"hematopoietic stromal cells","score":0.9290000200271606},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/flip","display_name":"c-FLIP","score":0.7139999866485596},{"id":"https://openalex.org/keywords/caspase-8","display_name":"caspase-8","score":0.8479999899864197},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.699999988079071},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.828000009059906},{"id":"https://openalex.org/keywords/soluble-factors","display_name":"soluble factors","score":0.6240000128746033},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.7250000238418579},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/fas-death-receptor","display_name":"Fas death receptor","score":0.656000018119812},{"id":"https://openalex.org/keywords/allogeneic-transplantation","display_name":"allogeneic transplantation","score":0.7350000143051147},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.550000011920929},{"id":"https://openalex.org/keywords/hematopoietic-stem-cells","display_name":"hematopoietic stem cells","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6945353746414185},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6930866241455078},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5680528879165649},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.42676645517349243},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42549124360084534},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4233548939228058},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4135618209838867},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3955155909061432},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33721038699150085},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33342480659484863},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3252999186515808},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23185482621192932},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.12707319855690002},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11930868029594421},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.08610469102859497}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bbmt.2006.12.067","doi":"https://doi.org/10.1016/j.bbmt.2006.12.067","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2006.12.067","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.bbmt.2006.12.067","doi":"https://doi.org/10.1016/j.bbmt.2006.12.067","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbmt.2006.12.067","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biology of Blood and Marrow Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2589579772","https://openalex.org/W2577320118","https://openalex.org/W2556689349","https://openalex.org/W1519816848","https://openalex.org/W2552291499","https://openalex.org/W2549220183","https://openalex.org/W2471731898","https://openalex.org/W2162628305","https://openalex.org/W1973626570","https://openalex.org/W2150160340"],"abstract_inverted_index":{"The":[0,318],"bone":[1],"marrow":[2,298],"microenvironment":[3,47,314],"provides":[4],"tumor":[5,46],"protection":[6],"from":[7],"chemotherapy":[8],"and":[9,37,77,102,114,176,198,292],"Fas-death":[10],"receptor":[11],"mediated":[12,20,50,277],"apoptosis":[13,95,216,248,269,278],"through":[14,96],"a":[15,25,66,100,145,246,280],"process":[16],"known":[17],"as":[18],"environmental":[19],"death":[21,136],"resistance":[22,55,249,274],"(EM-DR).":[23],"TRAIL,":[24],"member":[26],"of":[27,130,162,218,312,322],"the":[28,45,74,83,180,267,310,313],"TNF":[29],"superfamily,":[30],"has":[31],"anti-tumor":[32],"activity":[33],"sparing":[34],"normal":[35],"cells":[36,72,81,90,132,164,220,300],"mediates":[38],"allogeneic":[39,62],"graft-versus-tumor":[40],"responses.":[41],"We":[42],"hypothesized":[43],"that":[44,88,134,148,166,189,190,210,241,290],"influences":[48],"TRAIL":[49,126,215,268,276,323],"killing":[51],"conferring":[52],"an":[53,260],"immune":[54,319],"mechanism":[56],"contributing":[57],"to":[58,179,184,251,275],"cancer":[59],"progression":[60],"in":[61,65,73,82,99,107,156,170,222,234,257,279],"transplantation.":[63],"Experiments":[64],"transwell":[67],"(TW)":[68],"assay":[69],"with":[70,117,150,173,206,238,259,284],"RPMI-8226-Myeloma":[71],"upper":[75],"well":[76,85],"HS5-":[78],"hematopoietic":[79],"stromal":[80,299],"bottom":[84],"(TW+HS5)":[86,187],"revealed":[87],"HS5":[89],"blocked":[91],"recombinant":[92],"human(rh-)":[93],"TRAIL-induced":[94,316],"soluble":[97,185,191,294],"factors":[98,295],"dose":[101],"time-dependent":[103],"manner.":[104],"RPMI-8226":[105,131,163,219,236,255],"treated":[106,158,221,237,256],"TW+HS5":[108,157,258],"exhibited":[109],"attenuated":[110],"pro-caspase-8,":[111],"pro-caspase-3,":[112],"PARP,":[113],"BID":[115],"cleavage,":[116],"diminished":[118,247],"mitochondrial":[119],"membrane":[120],"potential":[121],"changes,":[122],"without":[123],"alterations":[124],"on":[125,315],"receptors.":[127],"Western":[128],"blotting":[129],"showed":[133,165],"Fas-associated":[135],"domain":[137],"like":[138],"IL-1":[139],"converting":[140],"enzyme-like":[141],"inhibitory":[142],"protein":[143],"(FLIP),":[144],"regulatory":[146],"factor":[147,186,192],"competes":[149],"caspase-8":[151],"inhibiting":[152],"apoptosis,":[153],"is":[154,168,177,232],"increased":[155],"cells.":[159],"Subcellular":[160],"fractionation":[161],"FLIP":[167,196,200,212,285,328],"maintained":[169],"or":[171,205],"associated":[172,283],"organelle":[174],"membranes":[175],"released":[178],"cytosol":[181],"when":[182],"exposed":[183],"suggesting":[188],"signaling":[193],"may":[194,324],"influence":[195,311],"localization":[197],"availability.":[199],"reduction":[201],"by":[202,297,305,327],"FLIP-RNA":[203],"interference":[204],"Bortezomib,":[207],"NF-KB":[208],"inhibitor":[209],"reduces":[211],"levels,":[213],"increases":[214],"sensitivity":[217],"TW+HS5.":[223],"To":[224],"explore":[225],"whether":[226],"IL-6,":[227],"important":[228],"myeloma":[229,302],"survival":[230,304],"factor,":[231],"involved":[233],"TRAIL-EMDR,":[235],"HS27a":[239],"stroma":[240],"lack":[242],"IL-6":[243,262,291],"secretion":[244],"elicit":[245],"compared":[250],"HS-5.":[252],"In":[253],"addition,":[254],"anti-human":[261],"neutralizing":[263],"antibody":[264],"partially":[265],"overcome":[266],"resistance.":[270],"Furthermore,":[271],"rh-IL-6":[272],"confers":[273],"dose-dependent":[281],"manner":[282],"increase.":[286],"Our":[287],"results":[288],"suggest":[289],"other":[293],"produced":[296],"promote":[301],"cell":[303],"upregulating":[306],"FLIP,":[307],"thereby":[308],"mitigating":[309],"apoptosis.":[317],"cytotoxic":[320],"effect":[321],"be":[325],"enhanced":[326],"inhibitors.":[329]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}